These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20637116)

  • 1. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces.
    Chen W; Tang S; Sun J; Ross-Degnan D; Wagner AK
    BMC Health Serv Res; 2010 Jul; 10():211. PubMed ID: 20637116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does economic incentive matter for rational use of medicine? China's experience from the essential medicines program.
    Chen M; Wang L; Chen W; Zhang L; Jiang H; Mao W
    Pharmacoeconomics; 2014 Mar; 32(3):245-55. PubMed ID: 23813440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are essential medicines in Malaysia accessible, affordable and available?
    Saleh K; Ibrahim MI
    Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing practices using WHO prescribing indicators and factors associated with antibiotic prescribing in six community pharmacies in Asmara, Eritrea: a cross-sectional study.
    Amaha ND; Weldemariam DG; Abdu N; Tesfamariam EH
    Antimicrob Resist Infect Control; 2019; 8():163. PubMed ID: 31649820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
    Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
    PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran.
    Cheraghali AM; Nikfar S; Behmanesh Y; Rahimi V; Habibipour F; Tirdad R; Asadi A; Bahrami A
    East Mediterr Health J; 2004 May; 10(3):406-15. PubMed ID: 16212218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
    Guan X; Hu H; Man C; Shi L
    Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji.
    Huang Y; Jiang Y; Zhang L; Mao W; van Boven JFM; Postma MJ; Chen W
    BMC Health Serv Res; 2018 Mar; 18(1):218. PubMed ID: 29587742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retail pharmacies in developing countries: a behavior and intervention framework.
    Goel P; Ross-Degnan D; Berman P; Soumerai S
    Soc Sci Med; 1996 Apr; 42(8):1155-61. PubMed ID: 8737433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
    Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
    PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdependence on For-Profit Pharmacies: A Descriptive Survey of User Evaluation of Medicines Availability in Public Hospitals in Selected Nigerian States.
    Ushie BA; Ugal DB; Ingwu JA
    PLoS One; 2016; 11(11):e0165707. PubMed ID: 27812177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. China issues the National Essential Medicines List (2018 edition): Background, differences from previous editions, and potential issues.
    He J; Tang M; Ye Z; Jiang X; Chen D; Song P; Jin C
    Biosci Trends; 2018; 12(5):445-449. PubMed ID: 30473550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
    Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
    Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.
    Wang J; Liu X; Wang S; Chen H; Wang X; Zhou W; Wang L; Zhu Y; Zheng X; Hao M
    Indian J Pharmacol; 2015; 47(5):535-9. PubMed ID: 26600644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off?
    Carasso BS; Lagarde M; Tesfaye A; Palmer N
    Trop Med Int Health; 2009 Nov; 14(11):1394-400. PubMed ID: 19754520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.